Nurse Practitioner, Family · New York, NY
NPI
1447490610
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
6
Medicare group memberships
Hospitals
2
Hospital affiliations
1275 York Ave
New York, NY, 10065
Phone (212) 639-2335
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
452 services
Medicare patients, 2024
357
Average age 74
Drug cost, 2024
$79K
535 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christine S Iovino was code 99214 (office e&m - established), 437 times for 349 patients. In total Christine S Iovino billed 452 services in 4 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 437 | 349 | $63.14 | $28K |
By year: 2022 $15K for 226 services; 2023 $15K for 234 services; 2024 $28K for 452 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christine S Iovino prescribed most often to Medicare patients was Anastrozole, with 289 prescriptions and refills. In total Christine S Iovino wrote 535 Medicare prescriptions that cost $79K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 289 | 801 | 104 | $6,780 |
| Letrozole Generic | 68 | 203 | 29 | $1,388 |
| Tamoxifen Citrate Generic | 57 | 139 | 18 | $1,728 |
| Exemestane Generic | 55 | 161 | 23 | $12K |
| Arimidex Anastrozole | 17 | 33 | Under 11 | $54K |
| Alendronate Sodium Generic | 15 | 42 | Under 11 | $128 |
Brand drugs: 39 claims; generic drugs: 496 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Christine S Iovino were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.